Specialty Pharma Journal Specialty, Precision & Technology
LEBANON, N.J., Sept. 21, 2017 /PRNewswire/ — Provention Bio, Inc., a clinical stage biopharmaceutical company …
Read More »Provention Bio Enters Licensing Agreement with Janssen for Two Mid-Stage GI Immunology Candidates
Recent Posts
Alternative Splicing, An Important Mechanism for Cancer
Barcelona, 21 September 2017 – Cancer, which is one of the leading causes of death …
Read More »AbbVie Announces Another Combination Trial Evaluating New ADC with Bristol-Myers Squibb’s Opdivo
NORTH CHICAGO, Ill. & NEW YORK–(BUSINESS WIRE)–AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a …
Read More »Versartis’ Growth Hormone Drug Fails to Meet Primary Endpoint of Non-Inferiority in Phase 3 Study
MENLO PARK, Calif., Sept. 21, 2017 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused biopharmaceutical …
Read More »Avrobio Expands Rare Disease Pipeline with Gene Therapy to Treat Pompe Disease
CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVROBIO, Inc., a clinical-stage biotechnology company developing transformative, life-changing gene therapies for rare …
Read More »‘Labyrinth’ Chip Could Help Monitor Aggressive Cancer Stem Cells
ANN ARBOR–Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels …
Read More »Unique Gene Therapy Prevents, Reverses Multiple Sclerosis in Animal Model
Multiple sclerosis can be inhibited or reversed using a novel gene therapy technique that stops …
Read More »FDA Grants Orphan Drug Designation to PhaseRx’s Rare Liver Disease Drug
SEATTLE, Sept. 20, 2017 /PRNewswire/ — PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing mRNA …
Read More »Sanofi and NIH Researchers Develop Three-in-One Antibodies to Treat HIV
CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire/ — In a landmark study published in the journal …
Read More »Alnylam’s Rare Disease Drug Meets Endpoints in Late-Stage hATTR Amyloidosis Study
CAMBRIDGE, Mass. & PARIS–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, and Sanofi Genzyme, the …
Read More »Acceleron Amends Agreement with Celgene, Taking Back Rights to PAH Candidate Sotatercept
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development …
Read More »Anthem, Inc. to Acquire HealthSun
INDIANAPOLIS–(BUSINESS WIRE)–Anthem, Inc. (NYSE:ANTM) today announced that the company has entered into an agreement to …
Read More »FDA Advisory Committee Split on Opinion of Adjuvant Sutent for High-Risk Renal Cell Carcinoma
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration’s (FDA) …
Read More »Catalent to Acquire Cook Pharmica for $950 Million
SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development …
Read More »AbbVie Announces Positive Results from Late-Stage Relapsed/Refractory Chronic Lymphocytic Leukemia Study
NORTH CHICAGO, Ill., Sept. 18, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, …
Read More »